Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response

被引:98
作者
Landau, Dan-Avi [4 ]
Saadoun, David [4 ]
Halfon, Philippe [1 ]
Martinot-Peignoux, Michelle [2 ]
Marcellin, Patrick [2 ]
Fois, Elena [3 ]
Cacoub, Patrice [4 ]
机构
[1] Lab Alphabio, Marseille, France
[2] Hop Beaujon, INSERM, U773 CRB3, F-92110 Clichy, France
[3] Hop Cochin, F-75674 Paris, France
[4] Univ Paris 06, CNRS, UMR 7087, APHP,Hop Pitie Salpetriere, F-75252 Paris 05, France
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 02期
关键词
D O I
10.1002/art.23305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the clinical characteristics, outcomes, and results of hepatitis C virus (HCV) RNA analyses in a group of patients with HCV-associated mixed cryoglobulinemia (MC) vasculitis who experienced a relapse of vasculitis despite achieving a sustained viral response to treatment with antiviral agents. Methods. HCV RNA testing was performed by the transcription-mediated amplification (TMA) method in sera and cryoprecipitates (detection limit 2.5 IU/ml). HCV replication was assessed in peripheral blood mononuclear cells (PBMCs) by a modified real-time polymerase chain reaction assay (detection limit 15 IU/10(6) cells). Results. We identified 8 patients with relapse of HCV-MC vasculitis despite their having achieved a sustained viral response to treatment. Relapse appeared early after the end of treatment (mean +/- SD 2.5 +/- 3.5 months) and included mainly purpura (n = 7) and arthralgia (n = 5). Relapse was associated with an increase in serum cryoglobulin levels as compared with end-of-treatment levels (mean +/- SD 0.3 +/- 0.09 gm/liter and 0.08 +/- 0.04 gm/liter, respectively; P < 0.01) and a decrease in C4 levels. In most patients, the relapse was brief, and the MC vasculitis manifestations subsided. A search for HCV RNA by TMA was negative in all patients tested (7 of 8 patients), both in sera and in cryoprecipitates. HCV replication was not found in PBMCs from any of the patients tested (6 of 8 patients). In 3 patients, the MC vasculitis symptoms persisted and were associated with elevated cryoglobulin levels. B cell lymphoma was diagnosed in 2 of these 3 patients. Conclusion. Relapse of MC vasculitis does occur in a few patients with HCV infection, despite achieving a sustained viral response, and this relapse is not related to persistence of virus. Relapse is short-lived and may be induced by the withdrawal of interferon alfa therapy. However, in patients with persistent MC vasculitis symptoms, a different underlying condition should be considered, especially B cell lymphoma.
引用
收藏
页码:604 / 611
页数:8
相关论文
共 37 条
[1]   Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN [J].
Alric, L ;
Plaisier, E ;
Théault, S ;
Péron, JM ;
Rostaing, L ;
Pourrat, J ;
Ronco, P ;
Piette, JC ;
Cacoub, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :617-623
[2]   Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles [J].
Arcaini, L ;
Paulli, M ;
Boveri, E ;
Vallisa, D ;
Bernuzzi, P ;
Orlandi, E ;
Incardona, P ;
Brusamolino, E ;
Passamonti, F ;
Burcheri, S ;
Schena, C ;
Pascutto, C ;
Cavanna, L ;
Margrini, U ;
Lazzarino, M .
CANCER, 2004, 100 (01) :107-115
[3]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[4]   Interferon-α and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis [J].
Cacoub, P ;
Lidove, O ;
Maisonobe, T ;
Duhaut, P ;
Thibault, V ;
Ghillani, P ;
Myers, RP ;
Leger, JM ;
Servan, J ;
Piette, JC .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3317-3326
[5]   Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection [J].
Casato, M ;
Agnello, V ;
Pucillo, LP ;
Knight, GB ;
Leoni, M ;
DelVecchio, S ;
Mazzilli, C ;
Antonelli, G ;
Bonomo, L .
BLOOD, 1997, 90 (10) :3865-3873
[6]   RENAL INVOLVEMENT IN ESSENTIAL MIXED CRYOGLOBULINEMIA [J].
DAMICO, G ;
COLASANTI, G ;
FERRARIO, F ;
SINICO, RA .
KIDNEY INTERNATIONAL, 1989, 35 (04) :1004-1014
[7]  
FERRI C, 1993, BLOOD, V81, P1132
[8]  
FRANKEL AH, 1992, Q J MED, V82, P101
[9]   PREVENTION OF EPSTEIN-BARR VIRUS-INDUCED B-CELL OUTGROWTH BY INTERFERON-ALPHA [J].
GARNER, JG ;
HIRSCH, MS ;
SCHOOLEY, RT .
INFECTION AND IMMUNITY, 1984, 43 (03) :920-924
[10]   Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse [J].
Gerotto, M ;
Dal Pero, F ;
Bortoletto, G ;
Ferrari, A ;
Pistis, R ;
Sebastiani, G ;
Fagiuoli, S ;
Realdon, S ;
Alberti, A .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :83-87